Clinical Trials in New York

Showing 15281-15300 of 22,668 trials

Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial

NCT01620983

Patients undergoing knee replacement surgery and who have high levels of pain catastrophizing are at risk for poor outcome. The clinical trial is designed to determine if a pain coping skills training intervention delivered by physical therapists and supervised by psychologists is more effective at reducing pain and improving function and is more cost effective than arthritis education or usual care.

Knee Osteoarthritis

Virginia Commonwealth University402 participantsStarted Dec 2012

Springfield, Illinois, United States • New York, New York, United States • Durham, North Carolina, United States +2 more locations

TERMINATEDPhase 1< 1 mile

A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

NCT02641002

Study CC-90002-AML-001 is an open-label, Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) infusion, in subjects with relapsed and/or primary refractory AML and high-risk MDS. The study will explore escalating doses of CC-90002 using a 3 + 3 dose escalation design in Part A, followed by dose expansion in Part B. The primary objective is to determine the safety and tolerability of CC-90002 and also to define the non-tolerated dose (NTD), the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-90002.

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Celgene28 participantsStarted Mar 2016

Phoenix, Arizona, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +3 more locations

Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial

A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Find Trials by Condition in New York

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)

Mobilization of Mesenchymal Stem Cells During Liver Transplantation

Treatment Study of Vitamin D Deficiency in Adolescents

Long-term Open-Label Safety Study to Evaluate EN3409

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

BKM120 for Patients With PI3K-activated Tumors

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods